Category III Code Invoked By Celsion In Breast Cancer Trial Billing
This article was originally published in The Gray Sheet
Executive Summary
Celsion's Category III CPT code denoting its Microfocus APA 1000 early-stage primary breast cancer treatment bodes well for building a reimbursement history, according to the firm
You may also be interested in...
ICD-10 Coding System Implementation Urged By AdvaMed, Hospital Groups
Two new Medicare hosptial inpatient coding systems should be implemented concurrently, a coalition of ICD-10 proponents asserts in a Nov. 19 letter to HHS National Committee on Vital and Health Statistics (NCVHS) Chairman John Lumpkin, MD, Illinois Department of Public Health
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.